“Efficacy and safety of antisense oligonucleotide therapies targeting APoC-III in patients with severe hypertriglyceridemia: a meta-analysis of randomized controlled trials” (2026) Monaldi Archives for Chest Disease [Preprint]. doi:10.4081/monaldi.2026.3543.